Treatment of lipid disorders in non-insulin-dependent diabetes mellitus

被引:7
作者
Gylling, H [1 ]
Miettinen, TA [1 ]
机构
[1] Univ Helsinki, Dept Med, Div Internal Med, FIN-00290 Helsinki, Finland
关键词
D O I
10.1097/00041433-199712000-00004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The basis for treatment of lipid disorders in patients with non-insulin-dependent diabetes mellitus is weight reduction by diet and exercise, and additional control of glycaemic condition with oral antidiabetics, alone or in combination with insulin. Hypercholesterolaemic, mildly hypertriglyceridaemic non-insulin-dependent diabetes mellitus patients respond to cholesterol malabsorption caused by dietary sitostanol ester margarine, while long-term statin treatment of respective coronary patients significantly lowers the recurrence of coronary events, in addition to improving the lipid disorder. However, no information is available concerning the preventive effect of long-term improvement of lipid disorders in non-insulin-dependent diabetes mellitus patients without coronary heart disease, or in patients with the `classical' type of diabetic lipid disorder, that is, hypertriglyceridaemia with low HDL and normal - low LDL-cholesterol levels. In this group of patients, beneficial lipid effects can be obtained (although perhaps not normalization) with fibrates alone or, especially, in combination with current statins.
引用
收藏
页码:342 / 347
页数:6
相关论文
共 74 条
[51]   REDUCTION OF SERUM-CHOLESTEROL WITH SITOSTANOL-ESTER MARGARINE IN A MILDLY HYPERCHOLESTEROLEMIC POPULATION [J].
MIETTINEN, TA ;
PUSKA, P ;
GYLLING, H ;
VANHANEN, H ;
VARTIAINEN, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1308-1312
[52]   Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects [J].
Naoumova, RP ;
Cummings, MH ;
Watts, GF ;
Rendell, NB ;
Taylor, GW ;
Sonksen, PH ;
Thompson, GR .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (04) :332-340
[53]   BEZAFIBRATE AFFECTS LIPID, LIPOPROTEIN AND APOLIPOPROTEIN PATTERN IN NON-INSULIN-DEPENDENT DIABETIC-PATIENTS [J].
NIORT, G ;
GAMBINO, R ;
CASSADER, M ;
PAGANO, G .
HORMONE AND METABOLIC RESEARCH, 1993, 25 (07) :372-374
[54]   INHIBITION OF LIPOLYSIS DECREASES LIPID OXIDATION AND GLUCONEOGENESIS FROM LACTATE BUT NOT FASTING HYPERGLYCEMIA OR TOTAL HEPATIC GLUCOSE-PRODUCTION IN NIDDM [J].
PUHAKAINEN, I ;
YKIJARVINEN, H .
DIABETES, 1993, 42 (12) :1694-1699
[55]   Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease - A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) [J].
Pyorala, K ;
Pedersen, TR ;
Kjekshus, J ;
Faergeman, O ;
Olsson, AG ;
Thorgeirsson, G .
DIABETES CARE, 1997, 20 (04) :614-620
[56]  
RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365
[57]   The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].
Sacks, FM ;
Pfeffer, MA ;
Moye, LA ;
Rouleau, JL ;
Rutherford, JD ;
Cole, TG ;
Brown, L ;
Warnica, JW ;
Arnold, JMO ;
Wun, CC ;
Davis, BR ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009
[58]  
Sattar N, 1996, DIABETIC MED, V13, P782, DOI 10.1002/(SICI)1096-9136(199609)13:9<782::AID-DIA177>3.3.CO
[59]  
2-9
[60]  
SCHNEIDER J, 1991, DIABETES METAB, V17, P185